CVRX logo

CVRx Inc. (CVRX)

$6.79

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on CVRX

Market cap

$178655812

EPS

-2.04

P/E ratio

--

Price to sales

2.84

Dividend yield

--

Beta

1.276201

Price on CVRX

Previous close

$6.11

Today's open

$6.44

Day's range

$6.42 - $7.22

52 week range

$4.30 - $14.04

Profile about CVRX

CEO

Kevin Hykes

Employees

206

Headquarters

Minneapolis, MN

Exchange

Nasdaq Global Select

Shares outstanding

26311607

Issue type

Common Stock

CVRX industries and sectors

Healthcare

Medical Equipment & Supplies

News on CVRX

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc. - CVRX

NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX).  Such investors are advised to contact Danielle Peyton at [email protected]  or 646-581-9980, ext. 7980.

news source

GlobeNewsWire • 6 hours ago

news preview

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc. - CVRX

NEW YORK, Feb. 19, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of CVRx, Inc. ("CVRx" or the "Company") (NASDAQ: CVRX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

news source

PRNewsWire • Feb 20, 2026

news preview

Securities Fraud Investigation Into CVRx, Inc. (CVRX) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON CVRX, INC. (CVRX), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On April 7, 2025, CVRx.

news source

Business Wire • Feb 19, 2026

news preview

CVRx, Inc. (CVRX) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN CVRX, INC. (CVRX), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@h.

news source

Business Wire • Feb 19, 2026

news preview

Securities Fraud Investigation Into CVRx, Inc. (CVRX) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON CVRX, INC. (CVRX), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is the Investigation About? On April 7, 2025, CVRx announced first quarter results, including revenue of only $12.

news source

Business Wire • Feb 19, 2026

news preview

CVRx, Inc. (CVRX) Q4 2025 Earnings Call Transcript

CVRx, Inc. (CVRX) Q4 2025 Earnings Call Transcript

news source

Seeking Alpha • Feb 13, 2026

news preview

CVRx (CVRX) Reports Q4 Loss, Tops Revenue Estimates

CVRx (CVRX) came out with a quarterly loss of $0.46 per share versus the Zacks Consensus Estimate of a loss of $0.42. This compares to a loss of $0.43 per share a year ago.

news source

Zacks Investment Research • Feb 12, 2026

news preview

CVRX INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving CVRx Inc.

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP continues its investigation on behalf of CVRx Inc. (“CVRx” or the “Company”) (NASDAQ:CVRX) investors concerning the Company's and/or members of its senior management's possible violation of the federal securities laws and other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On April 7, 2025, CVRx announced weaker than expected preliminary first quarter results. In the Company's earnings press releas.

news source

Business Wire • Feb 11, 2026

news preview

CVRx ALERT: Bragar Eagel & Squire, P.C. is Investigating CVRx Inc. on Behalf of CVRx Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In CVRx (CVRX) To Contact Him Directly To Discuss Their Options

news source

GlobeNewsWire • Jan 30, 2026

news preview

CVRx to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call on February 12, 2026

MINNEAPOLIS, Jan. 29, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that it plans to release fourth quarter 2025 financial and operating results after market close on Thursday, Feb. 12, 2026. The Company will host a conference call to review its results at 4:30 p.m. Eastern Time the same day.

news source

GlobeNewsWire • Jan 29, 2026

news preview

¹ Disclosures

Get started with M1

Invest in CVRx Inc.

Open an M1 investment account to buy and sell CVRx Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in CVRX on M1